ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener 🦋 Butterfly 8 Analysts 🏛️ Policy 🎬 Video ★ Watchlist 🎲 Prediction Markets 📊 RQD Track Record 📅 Next Catalysts 🛡️ Overlap & Crash X-Ray 📰 Live Wire 🐋 13F Whales 🏛️ Congress & CEO Buys 🏆 $100K Arena ⌘ Pro Terminal 📐 Methodology & Corrections
Stock Ratings / Health Care / THC / insiders
EHC (77) ENSG (72) UHS (63) PACS (74) ⌘ Pro Terminal →

Tenet Healthcare Corporation (THC) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$273.25 +0.99% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $274.39

Tenet Healthcare Corporation (THC) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (steady margins, 28% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate) →
ROARABLE B • BUY Cap $21.79B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on THC Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is THC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Tenet Healthcare Corporation (NYSE: THC) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $273.25 (+0.99% 1D, market cap $21.79B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, THC ranks #46 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does THC compare to EHC and ENSG in the Health Care sector?
▼

Within the Health Care sector (Hospital/Nursing Management), THC carries a Roarable B (74/100 RQD), trailing P/E of 9.2x, gross margin of —, and ROIC of 27.6%. By comparison, EHC (Encompass Health Corporation) holds a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B) and ENSG (The Ensign Group Inc.) posts a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for THC?
▼

Per THC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000070318), Tenet Healthcare Corporation generated $21.31B in revenue (+3.1% YoY), $2.37B in net income, and $2.53B in free cash flow against $29.68B in total assets and $9.32B in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $274.40 (+0.42%)🧬 Cannibal Buyback (-2.64% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 11.9% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERBUY • B
025507510074
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw A · Rk D+
Cash (17)Whales (18)SEC (10)Macro (12)CEO (17)
Each axis scored 0–20
12M PRICE TARGET CONE+7.2% Base Target
$346 Bull$293 Base$224 Bear
📬 FREE THC RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for THC)Realized 20D OHLCV Swing Band: ±6.1%
Deterministic 5-Pillar Attribution (74/100 Composite)
🔍 WHY THC SCORES 74/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+18/20 pts (24% of score)

20D Institutional Volume Accumulation (±6.1% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 11.9% FCF Margin ($2.53B FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk10/20 pts (-10 pt drag)

Balance-sheet & 10-K footnote risk deducts 10 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
66
Grade B-$266.91+2% Next Q
Q2 (-2Q)
69
Grade B-$272.32-3.8% Next Q
Q3 (-1Q)
71
Grade B$262.05+4.3% Next Q
Current
74
Grade B$273.25+7.3% Hist 90D α
Trajectory: B- (66) → B (74)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the THC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 74/100 (B) score, THC faces multiple-compression risk if 9.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.64% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($264.51) or 200D SMA ($220.92) invalidates the momentum regime and cuts Target Base ($292.92) toward Bear Floor ($224.06).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $THC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “THC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 74%NO 26%Trade / Inspect Odds →
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

THC Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (THC)

No recent open-market Form 4 cluster sales or emergency dumps flagged on THC. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (THC Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
THC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +47.42%⚡ TESTING RESISTANCE
2026-11-02O $268.5H $273.3L $268.5C $273.3VOL 1.46M
RES: $276.9SUP: $258.4SMA50: $264.5SMA200: $220.9
$291.8$255.4$219.1$182.7$146.3RES $276.9SUP $258.4$273.32026-05-042026-06-172026-08-042026-09-182026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

THC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 THC Butterfly Map → + Track THC →
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
-2.8%/yr Implied 5Y Growth

vs. +3.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on THC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for THC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for THC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (THC)

Health Care Rank #46 of 1016 ⚔️ EHC vs THC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (THC vs. EHC, ENSG, UHS, PACS)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Tenet Healthcare Corporation (THC) ranks #46 by composite RQD confidence (74/100, grade B) and #71 by equity capitalization ($21.79B). Within this direct 5-issuer industry benchmark cohort, UHS leads on earnings valuation at 7.0x trailing P/E, while THC leads on capital efficiency and profitability with 27.6% ROIC and — gross margin. EHC currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with THC at 74/100 (B).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
THC ACTIVE
Tenet Healthcare Corporation
B 74/100 9.2x — 27.6% +0.99% $21.79B Benchmark Subject
EHC
Encompass Health Corporation
B+ 77/100 22.9x — 13.8% +3.35% $12.97B /ehc-vs-thc →
ENSG
The Ensign Group Inc.
B 72/100 31.6x 20.1% 18.0% -2.58% $10.87B /ensg-vs-thc →
UHS
Universal Health Services Inc.
C 63/100 7.0x — 14.1% -0.32% $10.41B /uhs-vs-thc →
PACS
PACS Group Inc.
B 74/100 41.1x — 24.6% -3.76% $7.87B /pacs-vs-thc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000070318

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Tenet Healthcare Corporation (THC) reported GAAP revenue of $21.31B (+3.1% vs. FY2024 revenue of $20.68B , and +3.6% cumulative change since FY2023) , GAAP net income of $2.37B, operating cash flow of $3.54B, and free cash flow of $2.53B (+126.7% YoY). On the balance sheet, THC closed FY2025 with $29.68B in total assets against $9.32B in total debt (Altman Z-Score: 2.08, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $21.31B $2.37B $3.54B $2.53B $29.68B $9.32B
FY2024 (FY) 2024-12-31 $20.68B $4.06B $2.05B $1.12B $28.94B $9.18B
FY2023 (FY) 2023-12-31 $20.56B $1.31B $2.37B $1.45B $24.68B $5.77B

3. THC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is THC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Tenet Healthcare Corporation (NYSE: THC) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $273.25 (+0.99% 1D, market cap $21.79B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, THC ranks #46 in composite RQD confidence.

How does THC compare to EHC and ENSG in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), THC carries a Roarable B (74/100 RQD), trailing P/E of 9.2x, gross margin of —, and ROIC of 27.6%. By comparison, EHC (Encompass Health Corporation) holds a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $12.97B) and ENSG (The Ensign Group Inc.) posts a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for THC?

Per THC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000070318), Tenet Healthcare Corporation generated $21.31B in revenue (+3.1% YoY), $2.37B in net income, and $2.53B in free cash flow against $29.68B in total assets and $9.32B in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is THC trading relative to its 50-day, 200-day, and 52-week technical levels?

THC last traded at $273.25 (+0.99% on volume of 1,209,626 shares), positioning the stock +3.30% above its 50-day simple moving average ($264.51) and +23.69% above its 200-day simple moving average ($220.92). Across its 52-week range of $157.58 to $283.05, THC sits at the 92.2% percentile with a 14-day RSI of 54.8 (NEUTRAL RANGE) and an implied next-earnings move of ±6.1% ($256.58 to $289.92).

THC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are THC insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies THC leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

Direct Sub-Reports: THC RQD Cockpit THC 12M Forecast THC Earnings & Move THC Dividends & DRIP THC Insiders & 13F THC Whale Options THC Profit Sankey THC News & Why
ROARABLE RATING BRIEF • RQD 74/100 (B) ✓ STAGE-C NUMBER FIREWALL VERIFIED

THC — Tenet Healthcare Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:13:27Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, THC scores 74 out of 100 (letter grade B; verdict label "Roarable Buy — Good Risk/Reward"). The five pillars break down as follows:

  • Fundamental Cash Engine: 17 / 20. Per the RQD rating, this pillar reflects ROIC of 27.6% and an FCF yield of 11.61%. For an investor, this is the strongest evidence in the rating that the business converts capital into cash at a high rate relative to its cost, which supports the valuation case. The tradeoff is that high ROIC alongside a leveraged balance sheet (see below) means returns depend on continued operating performance.
  • Whale / 13F Flow: 18 / 20. Per the RQD rating, this pillar reflects institutional accumulation and options positioning. This is the highest pillar score, suggesting institutional positioning is supportive. However, the holders section in the source data is empty, so the underlying 13F detail cannot be independently verified here.
  • Insider Conviction: 17 / 20. Per the RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The insider transaction detail is not itemized in the source data, so the composition of this signal cannot be verified here.
  • Macro Regime Fit: 12 / 20. Per the RQD rating, this pillar reflects a beta of 0.97 and sector sensitivity. A beta near 1.0 implies the stock has tended to move roughly in line with the broad market, so it is not a low-volatility defensive profile by this measure, and the score indicates a moderate fit with the prevailing macro regime.
  • Forensic Balance Sheet: 10 / 20. Per the RQD rating, this pillar reflects Altman Z of 2.08, Piotroski F of 6/9, and Debt/Equity of 2.06. This is the weakest pillar and the main counterweight to the cash-engine strength. A Debt/Equity of 2.06 means the company carries substantial leverage, which increases sensitivity to any deterioration in cash flow or refinancing conditions.

Taken together, an investor should read the rating as a case built on strong cash generation and institutional support, offset by leverage and moderate macro sensitivity. The valuation inputs (P/E TTM of 9.2, Forward P/E of 8.6) appear on the market data side and reflect the price relative to earnings, but the rating itself does not state a fair-value estimate.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
270.57$21.79B9.28.66.329.40%0.97$157.58 - $283.0527.6%

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$21310.0M$3508.0M$2367.0MN/A$2530.0M$2883.0M$9316.8M
FY 2024$20675.0M$5956.0M$4064.0MN/A$1116.0M$3019.0M$9175.0M
FY 2023$20564.0M$2510.0M$1311.0MN/A$1448.6MN/A$5774.4M

Per the SEC financials, revenue was broadly flat across the three periods, while net income and operating income moved more variably, with FY 2024 showing the highest operating income and net income of the periods shown. Per the market data, operating margin is 16.5% and net margin is 11.1%. The Altman Z-Score (2.08) and Piotroski F-Score (6/9) are cited in the RQD rating, and the RQD rating references Debt/Equity of 2.06, indicating a leveraged balance sheet. Per the SEC financials, reported debt increased from $5774.4M in FY 2023 to $9316.8M in FY 2025.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts section, six items were reported, all tagged to THC:

  • Q3 earnings focus (catalyst, GREEN). A TradingView item asks whether the company can beat Q3 earnings on ambulatory care strength, flagged as a catalyst.
  • Q3 earnings call presentation (YELLOW). A Seeking Alpha item references a 2026 Q3 results earnings call presentation dated 2026-10-29.
  • Analyst and market commentary (YELLOW). Items from StockInvest.us, Yahoo Finance, Yahoo! Finance Canada, and www.debelegger.nl cover market action and institutional positioning in general terms; their summaries do not state specific findings.

Risk watch items: the source summaries are generic and do not state specific risks. Per the Butterfly Supply-Chain Graph, no proprietary signals are present. The news summaries do not provide substantive detail beyond the headlines and general descriptions.

Open Questions

  • What is the company's service-line and payer mix, and how do they drive the revenue trend shown in the SEC financials?
  • What explains the gap between FY 2024 operating income ($5956.0M) and FY 2025 operating income ($3508.0M), and does the source data attribute it to any specific cause?
  • How is the debt increase from $5774.4M (FY 2023) to $9316.8M (FY 2025) being used, and what is the maturity profile?
  • What are the specific holders, insider trades, and analyst price targets behind the RQD whale and insider pillar scores?
  • What do the Q3 earnings results referenced in the news items show, since the summaries do not state outcomes?

THC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Tenet Healthcare Corporation (THC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to THC Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

THC Bull vs. Bear Conversation Board — What's Your Call at $273.25?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON THC 🐻 33% BEARISH CONVICTION
1. Pick Your Side on THC:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH 🎯 Target: $319.27 (+18.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is THC (B • RQD 74/100) a Buy at $270.57?

Welcome to the THC (Tenet Healthcare Corporation) Roar Pit. Current RQD Composite is 74/100 (Roarable Buy — Good Risk/Reward) in Hospital/Nursing Management. Bulls point to capital efficiency (27.6% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $211.04 (-22.0%)
Spot @ $270.57

Pump the brakes on THC — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on THC, but look at what you are paying: 9.2x trailing P/E with tightening sector spreads. Unless Tenet Healthcare Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $338.21 (+25.0%)
Spot @ $270.57

THC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on THC, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $270.57 (52-wk range $157.58 - $283.05), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%